Medeiros, A., Bredemeier, M., Valim, V., Pinheiro, M., Macieira, C., Duarte, A., Stadler, B., Ranza, R., Bertolo, M., Miranda, J., Brenol, C., Castro, G., Fernandes, V., Titton, D., Sauma, F., Pereira, I., Botelho, R., Carvalho, H., Hayata, A., Louzada, P., Ranzolin, A., Studart, S., Castelar, G., Kakehasi, A., Bianchi, W., Acayaba, R., Silveira, I., Resende, H., Amaral, J., Rocha, L., Gazzeta, M., Carvalho, L., Schowalski, S., Feldman, D., Laurindo, I., Provenza, J., & , (n.d.). sAT0123 RISK FOR TUBERCULOSIS DURING TREATMENT WITH BIOLOGICAL THERAPY: IS IT TIME FOR REVIEWING SCREENING PROTOCOL? – RESULTS FROM BRAZILIAN REGISTRY OF BIOLOGICAL THERAPIES IN RHEUMATIC DISEASES (BIOBADABRASIL). Annals of the rheumatic diseases, 78, 1129–1130. http://access.bl.uk/ark:/81055/vdc_100144719090.0x000053